Invention Grant
- Patent Title: Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof
-
Application No.: US12722575Application Date: 2010-03-12
-
Publication No.: US08541367B2Publication Date: 2013-09-24
- Inventor: Jian-ning Liu
- Applicant: Jian-ning Liu
- Applicant Address: US MA Newton
- Assignee: Landing Biotech, Inc.
- Current Assignee: Landing Biotech, Inc.
- Current Assignee Address: US MA Newton
- Agency: Law Offices of Albert Wai-Kit Chan, PLLC
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention provides pladin (plasma anti-diabetic nucb2 peptide) polypeptide and functional equivalent thereof that are useful for treating diabetes. The present invention provides a method of treating diabetes by administering to a subject nesfatin-1, pladin, or a functional equivalent thereof. The present invention also provides a method of treating diabetes by administering to subject plasmin inhibitors.
Public/Granted literature
- US20100235935A1 PLASMA ANTI-DIABETIC NUCB2 PEPTIDE (PLADIN) AND USES THEREOF Public/Granted day:2010-09-16
Information query
IPC分类:
